FDA issues new Plavix warning
The agency released a statement Friday regarding the inability of some patients to process the drug.
Washington (WiredPRNews.com) – The Food and Drug Administration has issued a black box warning for the drug Plavix. As reported by the Associated Press (AP), the FDA released a statement Friday saying some individuals may have an inability to metabolize the blood thinner, which is prescribed for the prevention of blood clots, due to a genetic variation, which may increase their risks of heart attack and stroke.
The FDA is quoted by the AP as stating in a statement released online, “Patients should not stop taking Plavix unless told to do so by their health care professional… They should talk with their health care professional if they have any concerns about Plavix, or to find out if they should be tested for being a poor metabolizer.”
WiredPRNews.com – The latest in Medical News
Photo Credit: Wikipedia User Trounce
Tags: black box warning, blood thinner, FDA, heart attack, metabolize, metabolizer, Plavix, strokeOnline Medical News News Press Release Distribution - WiredPRNews.com
- New Accounts on the Rise for Physical Therapy Exercise Software Company
- Pass your Urine Test Guaranteed
- Making Drug Testing Worry Free
- Prior Lake Orthodontics Expert & Owner of Cosmopolitan Orthodontics Opens Savage Office
- New Quotient ADHD System Used by NJ Psychiatrist
- Las Vegas Orthodontics Provider Joins Invisalign Teen Promotion
- HCG Diet Dangers and Myths Debunked
- Utah Based Rehab Center Recovery Ways Receives JCAHO Accreditation
- Denver Orthodontics Office Offers the Best Technology and Highest Quality Care
- See new HCG Diet before and after photos
